Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 16 01 2024
accepted: 17 06 2024
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 30 7 2024
Statut: epublish

Résumé

Endoscopic submucosal dissection is a standard treatment for early esophageal squamous cell carcinoma. However, submucosal or lymphovascular invasion increases the risk of lymph node metastasis. Although

Identifiants

pubmed: 39080310
doi: 10.1038/s41598-024-65066-5
pii: 10.1038/s41598-024-65066-5
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D
Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17493

Informations de copyright

© 2024. The Author(s).

Références

Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144, 1941–1953 (2019).
doi: 10.1002/ijc.31937 pubmed: 30350310
Pennathur, A., Gibson, M. K., Jobe, B. A. & Luketich, J. D. Oesophageal carcinoma. Lancet 381, 400–412 (2013).
doi: 10.1016/S0140-6736(12)60643-6 pubmed: 23374478
Uedo, N. et al. Role of narrow band imaging for diagnosis of early-stage esophagogastric cancer: Current consensus of experienced endoscopists in Asia-Pacific region. Dig. Endosc. 23(Suppl 1), 58–71 (2011).
doi: 10.1111/j.1443-1661.2011.01119.x pubmed: 21535204
Ishihara, R. Endoscopic diagnosis and treatment of superficial esophageal squamous cell cancer: Present status and future perspectives. Curr. Oncol. 29, 534–543 (2022).
doi: 10.3390/curroncol29020048 pubmed: 35200548 pmcid: 8870955
Kitagawa, Y. et al. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: Part 1. Esophagus 20, 343–372 (2023).
doi: 10.1007/s10388-023-00993-2 pubmed: 36933136 pmcid: 10024303
Minashi, K. et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology 157, 382-390.e3 (2019).
doi: 10.1053/j.gastro.2019.04.017 pubmed: 31014996
Oyama, T. et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: Magnifying endoscopic classification of the Japan esophageal society. Esophagus 14, 105–112 (2017).
doi: 10.1007/s10388-016-0527-7 pubmed: 28386209
Inoue, H. Endoscopic diagnosis of tissue atypism (EA) in the pharyngeal and esophageal squamous epithelium; IPCL pattern classification and ECA classification. Kyobu Geka 60, 768–775 (2007).
pubmed: 17763682
Yamaguchi, H. et al. Prediction of depth of invasion and lymph node metastasis in superficial pharyngeal cancer by magnifying endoscopy using the Japan esophageal society classification. DEN Open 3, e151 (2023).
doi: 10.1002/deo2.151 pubmed: 35898848
Thie, J. A. Understanding the standardized uptake value, its methods, and implications for usage. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. 45, 1431–1434 (2004).
Mantziari, S. et al. 18F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer. BMC Med. Imaging 20, 7 (2020).
doi: 10.1186/s12880-019-0401-x pubmed: 31969127 pmcid: 6977262
Lin, D. et al. The role of primary tumor SUVmax in the diagnosis of invasion depth: A step toward clinical T2N0 esophageal cancer. Ann. Transl. Med. 9, 112 (2021).
doi: 10.21037/atm-20-4430 pubmed: 33569414 pmcid: 7867900
Yildirim, B. A., Torun, N., Guler, O. C. & Onal, C. Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy. Nucl. Med. Commun. 39, 553–563 (2018).
doi: 10.1097/MNM.0000000000000837 pubmed: 29668513
Naito, S. et al. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig. Endosc. 34, 793–804 (2022).
doi: 10.1111/den.14154 pubmed: 34599604
Katada, C. et al. Retrospective assessment of the diagnostic accuracy of the depth of invasion by narrow band imaging magnifying endoscopy in patients with superficial esophageal squamous cell carcinoma. J. Gastrointest. Cancer 50, 292–297 (2019).
doi: 10.1007/s12029-018-0075-6 pubmed: 29435906
Radlinski, M. & Shami, V. M. Role of endoscopic ultrasound in esophageal cancer. World J. Gastrointest. Endosc. 14, 205–214 (2022).
doi: 10.4253/wjge.v14.i4.205 pubmed: 35634483 pmcid: 9048493
Thosani, N. et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: A systematic review and meta-analysis. Gastrointest. Endosc. 75, 242–253 (2012).
doi: 10.1016/j.gie.2011.09.016 pubmed: 22115605
Ishihara, R. et al. Assessment of the diagnostic performance of endoscopic ultrasonography after conventional endoscopy for the evaluation of esophageal squamous cell carcinoma invasion depth. JAMA Netw. Open 4, e2125317 (2021).
doi: 10.1001/jamanetworkopen.2021.25317 pubmed: 34524432 pmcid: 8444025
Toriyama, K. et al. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J. Gastroenterol. 25, 6767–6780 (2019).
doi: 10.3748/wjg.v25.i46.6767 pubmed: 31857778 pmcid: 6920656
Jeon, J. H. et al. Prognostic significance of venous invasion and maximum standardized uptake value of 18F-FDG PET/CT in surgically resected T1N0 esophageal squamous cell carcinoma. Eur. J. Surg. Oncol. 43, 471–477 (2017).
doi: 10.1016/j.ejso.2016.11.002 pubmed: 27912930
Gu, Y.-M. et al. Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma. Ann. Transl. Med. 7, 256 (2019).
doi: 10.21037/atm.2019.05.23 pubmed: 31355223 pmcid: 6614317
Li, Y. et al. Contrast-enhanced CT-based radiomics analysis in predicting lymphovascular invasion in esophageal squamous cell carcinoma. Front. Oncol. 11, 644165 (2021).
doi: 10.3389/fonc.2021.644165 pubmed: 34055613 pmcid: 8162215
Lin, C.-Y. et al. Predictive value of 18F-FDG PET/CT for vascular invasion in patients with hepatocellular carcinoma before liver transplantation. Clin. Nucl. Med. 42, e183–e187 (2017).
doi: 10.1097/RLU.0000000000001545 pubmed: 28114226
Yang, Y. et al. Preoperative prediction of lymphovascular invasion of colorectal cancer by radiomics based on 18F-FDG PET-CT and clinical factors. Front. Radiol. 3, 1212382 (2023).
doi: 10.3389/fradi.2023.1212382 pubmed: 37614530 pmcid: 10442652
Li, C., Tian, Y., Shen, Y., Wen, B. & He, Y. Utility of volumetric metabolic parameters on preoperative FDG PET/CT for predicting tumor lymphovascular invasion in non-small cell lung cancer. AJR Am. J. Roentgenol. 217, 1433–1443 (2021).
doi: 10.2214/AJR.21.25814 pubmed: 33978465
Griffeth, L. K. Use of PET/CT scanning in cancer patients: technical and practical considerations. Proc. (Bayl. Univ. Med. Cent.) 18, 321–330 (2005).
pubmed: 16252023
Rice, T. W., Patil, D. T. & Blackstone, E. H. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: Application to clinical practice. Ann. Cardiothorac. Surg. 6, 119–130 (2017).
doi: 10.21037/acs.2017.03.14 pubmed: 28447000 pmcid: 5387145
Hirata, K. et al. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS One 9, e105682 (2014).
doi: 10.1371/journal.pone.0105682 pubmed: 25162396 pmcid: 4146536

Auteurs

Hisaya Tanaka (H)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Keiichi Hashiguchi (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Endoscopy, Nagasaki University Hospital, Nagasaki, Japan.

Maiko Tabuchi (M)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki City, Nagasaki, 852-8523, Japan.

Arman Nessipkhan (A)

Department of Radioisotope Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.

Taro Akashi (T)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Junya Shiota (J)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Moto Kitayama (M)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Kayoko Matsushima (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Medical Education Development Center, Nagasaki University Hospital, Nagasaki, Japan.

Naoyuki Yamaguchi (N)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Endoscopy, Nagasaki University Hospital, Nagasaki, Japan.

Junichi Arai (J)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Kengo Kanetaka (K)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Masahiro Nakashima (M)

Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.

Takashi Kudo (T)

Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.

Kazuhiko Nakao (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Yuko Akazawa (Y)

Department of Histology and Cell Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki City, Nagasaki, 852-8523, Japan. akazaway@nagasaki-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH